St. Paul Heart Clinic Report issue

Academic/Hospital Phase 3 Phase 4
Founded: St. Paul MN United States (1974)

Organization Overview

First Clinical Trial
2003
NCT00123643
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Glucose Intolerance (Phase 4)

Obesity, Abdominal (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7